Kiacta eprodisate regulatory update

Bellus said Japan's Ministry of Health, Labor and Welfare (MHLW) granted Orphan Drug designation for Kiacta eprodisate to treat amyloid A (AA) amyloidosis. The small molecule inhibitor of amyloid fibe...